NeuroSense Therapeutics
NRSN
NRSN
7 hedge funds and large institutions have $286K invested in NeuroSense Therapeutics in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
CF
Cantor Fitzgerald
New York
|
$101K |
2 |
Citadel Advisors
Miami,
Florida
|
$43.5K |
3 |
XT
XTX Topco
George Town,
Cayman Islands
|
$58.4K |
4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
$16K |
Top Sellers
1 |
AC
Armistice Capital
New York
|
$0 |
2 |
Morgan Stanley
New York
|
$0 |
3 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
$0 |